The purpose of this study is to evaluate clinical safety issues pertaining to flupenthixol,
to cocaine, and to their interaction, and to determine how pretreatment with flupenthixol
modifies the subjective as well as physiological effects of cocaine. Taken together, these
relatively D-1 selective agents can help determine the extent to which DA-1 binding affects
the reinforcing effects of stimulants.